Lemaitre, F., Chakrama, F., O'Grady, T., Peulen, O., Rademaker, G., Deward, A., Chabot, B., Piette, J., Colige, A., Lambert, C., Dequiedt, F., & Habraken, Y. (30 May 2023). The transcription factor c-Jun mediates specific reprogramming of pre-mRNA splicing during platinum-based therapy via RBM39 [Poster presentation]. 28th Annual International Conference of the RNA society RNA 2023, Singapore. |
Lemaitre, F.* , Chakrama, F.* , O'Grady, T., Chabot, B., Piette, J., Colige, A., Lambert, C., Dequiedt, F.* , & Habraken, Y.*. (02 February 2023). The transcription factor c-Jun mediates specific reprogramming of pre-mRNA splicing during platinum-based therapy via RBM39 [Poster presentation]. séminaire des chercheurs Télévie 2023. * These authors have contributed equally to this work. |
Lemaitre, F.* , Chakrama, F.* , O'Grady, T., Peulen, O., Rademaker, G., Deward, A., Chabot, B., Piette, J., Colige, A., Lambert, C., Dequiedt, F.* , & Habraken, Y.*. (09 December 2022). The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress. Nucleic Acids Research, 50 (22), 12768 - 12789. doi:10.1093/nar/gkac1130 * These authors have contributed equally to this work. |
Lemaitre, F.* , Chakrama, F.* , O'Grady, T., Chabot, B., Piette, J., Colige, A., Lambert, C., Dequiedt, F.* , & Habraken, Y.*. (09 September 2022). The transcription factor c-Jun inhibits RBM39 to reprogram mRNA splicing during genotoxic stress [Poster presentation]. Interuniversity PhD student day. * These authors have contributed equally to this work. |
Lemaitre, F. (06 September 2022). The transcription factor c-Jun inhibits RBM39 to reprogram mRNA splicing during genotoxic stress [Paper presentation]. GIGA DAY 2022. |
Lemaitre, F.* , Chakrama, F.* , O'Grady, T., Dequiedt, F.* , & Habraken, Y.*. (08 April 2022). c-Jun directly controls spliceosome specificity through RBM39 binding in response to genotoxic chemotherapy [Poster presentation]. séminaire des chercheurs Télévie 2022. * These authors have contributed equally to this work. |
Lemaitre, F.* , Chakrama, F.* , Dequiedt, F.* , & Habraken, Y.*. (17 March 2022). c-Jun directly controls spliceosome specificity through RBM39 binding in response to genotoxic chemotherapy [Poster presentation]. Multiple facets of RNA in development and disease. * These authors have contributed equally to this work. |
Lemaitre, F., Chakrama, F., O'Grady, T., Chabot, B., Piette, J., Colige, A., Lambert, C., Dequiedt, F., & Habraken, Y. (March 2022). The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress [Poster presentation]. THE MULTIPLE FACETS OF RNA IN DEVELOPMENT AND DISEASE, Nice, France. |
Lemaitre, F., Chakrama, F., Dequiedt, F., Chabot, B., Klinck, R., Colige, A., Piette, J., Lambert, C., & Habraken, Y. (15 April 2021). c-Jun and RBM39 co-regulate alternative splicing induced by chemotherapy compounds [Poster presentation]. Joint Course on Post-Transcriptional Gene Regulation and Genome Instability, Paris, France. |
Chakramah, F., Lemaitre, F., Dequiedt, F., Chabot, B., Klink, R., Colige, A., Piette, J., Lambert, C., & Habraken, Y. (July 2020). c-Jun and RBM39 co-regulate alternative splicing induced by chemotherapy compounds [Poster presentation]. Third international Caparica conference in splicing, Caparica, Portugal. |